Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4585149
Max Phase: Preclinical
Molecular Formula: C72H108N22O18S2
Molecular Weight: 1633.93
Molecule Type: Unknown
Associated Items:
ID: ALA4585149
Max Phase: Preclinical
Molecular Formula: C72H108N22O18S2
Molecular Weight: 1633.93
Molecule Type: Unknown
Associated Items:
Canonical SMILES: N=C(N)NCCC[C@@H]1NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CSSC[C@H](NC1=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N2
Standard InChI: InChI=1S/C72H108N22O18S2/c73-26-6-4-15-44-60(102)89-50(37-95)63(105)85-46(16-5-7-27-74)68(110)94-32-12-21-55(94)70(112)93-31-11-20-54(93)66(108)84-45(18-9-29-80-72(77)78)61(103)91-52-39-114-113-38-51(64(106)86-47(62(104)83-44)33-41-22-24-42(96)25-23-41)90-59(101)43(17-8-28-79-71(75)76)82-56(97)36-81-58(100)48(35-57(98)99)87-67(109)53-19-10-30-92(53)69(111)49(88-65(52)107)34-40-13-2-1-3-14-40/h1-3,13-14,22-25,43-55,95-96H,4-12,15-21,26-39,73-74H2,(H,81,100)(H,82,97)(H,83,104)(H,84,108)(H,85,105)(H,86,106)(H,87,109)(H,88,107)(H,89,102)(H,90,101)(H,91,103)(H,98,99)(H4,75,76,79)(H4,77,78,80)/t43-,44-,45-,46-,47-,48-,49-,50-,51-,52-,53-,54-,55-/m0/s1
Standard InChI Key: OXVNYJZNIFYHIL-YDGUPJBKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1633.93 | Molecular Weight (Monoisotopic): 1632.7653 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Swedberg JE, Wu G, Mahatmanto T, Durek T, Caradoc-Davies TT, Whisstock JC, Law RHP, Craik DJ.. (2019) Highly Potent and Selective Plasmin Inhibitors Based on the Sunflower Trypsin Inhibitor-1 Scaffold Attenuate Fibrinolysis in Plasma., 62 (2): [PMID:30520638] [10.1021/acs.jmedchem.8b01139] |
Source(1):